Orphanet: Essai clinique de phase III comparant la thérapie de conditionnement à base de Tréosulfan avec un conditionnement à intensité réduite CIR à base de Busulfan, préalablement à la transplantation allogénique de cellules souches hématopoïétiques, chez les patients atteints de LAM ou du syndrome myélodysplasique SMD, considérés comme inéligibles aux régimes de conditionnement standard
x

Search for a clinical trial

* (*) mandatory field

Clinical Phase III Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Reduced-intensity Conditioning (RIC) Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With AML or MDS Considered Ineligible to Standard Conditioning Regimens - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : Medac gmbh
    • Phase : III
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.